Tislelizumab Combined With Fruquintinib for Metastatic pMMR/MSS Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Alternating Treatment With Fruquintinib and Bevacizumab Plus Capecitabine as Maintenance Therapy After First-Line Treatment in Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With MSI-H/dMMR Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- NA
Predictive Value of ctDNA for NED Status in mCRC and Its Utility in Guiding Therapeutic Intervention
- Status
- RECRUITING
- Phase
- NA
The Efficacy and Safety of Fruquintinib Plus FOLFIRI/FOLFOX as Second-line Treatment in Patients With RAS-mutant Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Effect of Silymarin in Metastatic Colorectal Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE3
Electroporation and Immunotherapy in Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation
- Status
- COMPLETED
- Phase
- PHASE2
The Efficacy and Safety of Fruquintinib Plus Chemotherapy as Second-line Treatment in Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
An Observational Study, Called RegoFlex EU, to Learn More About the Use of Stivarga at Reduced Doses as Recommended (Flexible Dosing) to Treat People With Metastatic Colorectal Cancer in Real World Settings in Europe
- Status
- COMPLETED
- Phase
- N/A
18FFDG PET/CT for Early Evaluation of Chemotherapy Efficacy in Metastatic Colic Adenocarcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Safety and Efficacy of Fruquintinib+FOLFIRI in RAS-mutated Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
MNK Inhibitor AUM001 in Combination With Either Pembrolizumab or Irinotecan to Treat Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Fruquintinib Sequential BEV+FOLFIRI vs. BEV+FOLFIRI Sequential Fruquintinib in Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
TARGETed Therapy Drug MONITOring in DIGestive Oncology
- Status
- RECRUITING
- Phase
- NA